Kyverna Therapeutics, Inc. Common Stock (KYTX) Analyst Forecast

$5.52

south_east
-$0.56 (-9.21%)
Day's range
$5.46
Day's range
$6.25

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
12/04/2025 Morgan Stanley Michael Ulz $25.00 $7.79   220.92%

Kyverna Therapeutics, Inc. FAQ's

Kyverna Therapeutics, Inc. has been rated by research analysts at Morgan Stanley, H.C. Wainwright in the past 90 days.